Dogwood Therapeutics DWTX
NASDAQ DWTX
$1.10 -0.07 (-5.98%)
As of: Oct 22, 2026 · 11:40 AM EDT

Dogwood Therapeutics (DWTX) Preferred Stock Liabilities (2024 - 2025)

Updated

Dogwood Therapeutics' Preferred Stock Liabilities was $70.13 million in Q3 2025, down 7.3% from the prior quarter.

Analysis

Dogwood Therapeutics (DWTX) Preferred Stock Liabilities (2024 - 2025) Analysis & Trends

At the end of FY2024, Preferred Stock Liabilities at Dogwood Therapeutics came in at $74.41 million.

  • Per Business Quant data, DWTX's Preferred Stock Liabilities in the three quarters before Q3 2025 was $75.66 million (Q2 2025), $75.66 million (Q1 2025) and $74.41 million (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,172.00 Bn 1,140.58 Bn 19.71 Bn -
2 Johnson & Johnson 639.12 Bn 557.64 Bn 17.26 Bn -
3 AbbVie 502.23 Bn 475.34 Bn 12.70 Bn -
4 Merck 375.29 Bn 329.67 Bn 12.21 Bn -
5 Novartis Ag 302.99 Bn 266.98 Bn 11.24 Bn -
6 Astrazeneca 268.68 Bn 242.36 Bn 12.86 Bn -
7 Amgen 242.24 Bn 197.64 Bn 7.24 Bn -
8 Gilead Sciences 193.36 Bn 167.56 Bn 6.22 Bn -
9 Pfizer 172.57 Bn 119.21 Bn 10.94 Bn -
10 Dogwood Therapeutics 37.54 Mn -1.95 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 70.13 Mn
Jun 30, 2025 75.66 Mn
Mar 31, 2025 75.66 Mn
Dec 31, 2024 74.41 Mn
API Access

Dogwood Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=DWTX&period=max&api_key=YOUR_API_KEY